The U.S. Congress has been quietly making progress on a couple of key pieces of legislation, and investors should be aware of which bills will matter to markets.

Michael Zezas: Legislation that Matters to Markets

Short, thoughtful and regular takes on recent events in the markets from a variety of perspectives and voices within Morgan Stanley.

Business

Investing

Careers

Management & Marketing

Business News

Shopping

With interest in anti-obesity medications growing significantly, the head of our European Pharmaceuticals Team examines just how large that market could become.

Meeting the Demand for Anti-Obesity Treatment

As the US presidential election remains closely contested, our experts discuss what a change in administration could mean for European equities in terms of trade, China relations and other key issues.

European Markets React to Upcoming U.S. Election

New data on both immigration and inflation defied predictions and may have shifted the Fed’s perspective.

US Economy: Bigger, But Not Tighter

Recent data indicates the economy may avoid either a soft or hard landing for now. Our Chief U.S. Equity Strategist explains why investors should seek out quality as the economy stays aloft.

U.S. Equities: No Landing in Sight

Japan and India are currently set to lead growth in these markets, but a higher-for-longer rate environment in the U.S. could favor China, Hong Kong and others, according to our analyst.

Michael Zezas: Legislation that Matters to Markets

Download our free app to listen on your phone